文献速递焦虑、强迫与应激相关障碍

慢性催产素驱动Crfr2α可变剪接诱导焦虑

Chronic oxytocin-driven alternative splicing of Crfr2α induces anxiety.
PubMed 文献 · Mol Psychiatry · 2021-05-25

该研究在大鼠中发现,持续两周的催产素治疗可增加焦虑样行为,雌性更敏感,且该效应在输注结束5天后消退。行为变化伴随下丘脑Crfr2α可变剪接从膜结合型向可溶型偏移,可溶型水平与焦虑样行为正相关。

要点

  • 慢性催产素治疗两周增加大鼠焦虑样行为,雌性敏感性更高。
  • 焦虑效应伴随下丘脑Crfr2α剪接向可溶型偏移。
  • 可溶型Crfr2α释放入脑脊液且水平与焦虑样行为正相关。

核心结论

  • 慢性催产素治疗通过驱动Crfr2α可变剪接向可溶型偏移而诱导焦虑样行为。

研究设计与样本

  • 研究在大鼠中进行,给予持续两周的慢性催产素治疗。

主要发现

  • 慢性催产素治疗两周增加大鼠焦虑样行为,雌性敏感性更高,与急性催产素 anxiolytic 效应相反。
  • 焦虑增加为暂时性,输注结束5天后消退。
  • 慢性催产素使下丘脑Crfr2α剪接比例从膜结合型向可溶型偏移。
  • 实验诱导可变剪接模拟慢性催产素的致焦虑效应,而可溶型Crfr2α敲低减少雄性大鼠焦虑相关行为。
  • 慢性催产素触发可溶型Crfr2α释放入脑脊液,其水平与焦虑样行为正相关。

临床怎么用

  • 长期鼻内催产素治疗需关注焦虑不良反应,尤其雌性。
  • 可溶型Crfr2α或可作为慢性催产素致焦虑的监测标志。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The neuropeptide oxytocin (OXT) has generated considerable interest as potential treatment for psychiatric disorders, including anxiety and autism spectrum disorders. However, the behavioral and molecular consequences associated with chronic OXT treatment and chronic receptor (OXTR) activation have scarcely been studied, despite the potential therapeutic long-term use of intranasal OXT. Here, we reveal that chronic OXT treatment over two weeks increased anxiety-like behavior in rats, with higher sensitivity in females, contrasting the well-known anxiolytic effect of acute OXT. The increase in anxiety was transient and waned 5 days after the infusion has ended. The behavioral effects of chronic OXT were paralleled by activation of an intracellular signaling pathway, which ultimately led to alternative splicing of hypothalamic corticotropin-releasing factor receptor 2α (Crfr2α), an important modulator of anxiety. In detail, chronic OXT shifted the splicing ratio from the anxiolytic membrane-bound (mCRFR2α) form of CRFR2α towards the soluble CRFR2α (sCRFR2α) form. Experimental induction of alternative splicing mimicked the anxiogenic effects of chronic OXT, while sCRFR2α-knock down reduced anxiety-related behavior of male rats. Furthermore, chronic OXT treatment triggered the release of sCRFR2α into the cerebrospinal fluid with sCRFR2α levels positively correlating with anxiety-like behavior. In summary, we revealed that the shifted splicing ratio towards expression of the anxiogenic sCRFR2α underlies the adverse effects of chronic OXT treatment on anxiety.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Winter J, Meyer M, Berger I, et al. Chronic oxytocin-driven alternative splicing of Crfr2α induces anxiety. Mol Psychiatry. 2021. PMID: 34035479. doi:10.1038/s41380-021-01141-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。